Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.21M Sell
93,334
-26,423
-22% -$691K 0.02% 287
2026
Q1
$3.33M Sell
119,757
-18,468
-13% -$492K 0.04% 221
2025
Q4
$3.52M Sell
138,225
-7,931
-5% -$200K 0.04% 219
2025
Q3
$4M Sell
146,156
-18,035
-11% -$445K 0.05% 209
2025
Q2
$3.98M Sell
164,191
-10,000
-6% -$233K 0.05% 218
2025
Q1
$4.41M Sell
174,191
-19,083
-10% -$499K 0.06% 209
2024
Q4
$5.13M Sell
193,274
-13,365
-6% -$363K 0.07% 199
2024
Q3
$5.98M Sell
206,639
-31,490
-13% -$919K 0.08% 191
2024
Q2
$6.66M Sell
238,129
-245,238
-51% -$6.75M 0.09% 173
2024
Q1
$13.4M Buy
483,367
+10,729
+2% +$298K 0.2% 109
2023
Q4
$13.6M Sell
472,638
-43,584
-8% -$1.32M 0.22% 97
2023
Q3
$17.1M Buy
516,222
+2,342
+0.5% +$82.8K 0.3% 77
2023
Q2
$18.8M Sell
513,880
-11,262
-2% -$438K 0.33% 74
2023
Q1
$21.4M Buy
525,142
+1,255
+0.2% +$54.2K 0.39% 66
2022
Q4
$26.8M Buy
523,887
+1,230
+0.2% +$59K 0.52% 44
2022
Q3
$22.9M Buy
522,657
+6,031
+1% +$293K 0.48% 52
2022
Q2
$27.1M Buy
516,626
+7,086
+1% +$361K 0.55% 45
2022
Q1
$26.4M Buy
509,540
+5,874
+1% +$305K 0.44% 53
2021
Q4
$29.7M Buy
503,666
+5,637
+1% +$279K 0.48% 53
2021
Q3
$21.4M Sell
498,029
-2,348
-0.5% -$104K 0.39% 65
2021
Q2
$19.6M Buy
500,377
+4,081
+0.8% +$159K 0.35% 71
2021
Q1
$18M Buy
496,296
+6,557
+1% +$233K 0.35% 73
2020
Q4
$18M Sell
489,739
-21,089
-4% -$774K 0.39% 66
2020
Q3
$17.8M Buy
510,828
+4,112
+0.8% +$144K 0.42% 57
2020
Q2
$15.7M Sell
506,716
-82,879
-14% -$2.82M 0.44% 58
2020
Q1
$18.3M Sell
589,595
-9,196
-2% -$313K 0.6% 41
2019
Q4
$22.3M Sell
598,791
-4,016
-0.7% -$143K 0.58% 40
2019
Q3
$20.5M Buy
602,807
+14,888
+3% +$541K 0.59% 39
2019
Q2
$24.2M Buy
587,919
+6,913
+1% +$275K 0.71% 34
2019
Q1
$23.4M Sell
581,006
-103,807
-15% -$4.16M 0.72% 31
2018
Q4
$28.4M Buy
684,813
+4,746
+0.7% +$197K 0.98% 19
2018
Q3
$28.4M Sell
680,067
-13,413
-2% -$516K 0.89% 22
2018
Q2
$23.9M Sell
693,480
-20,355
-3% -$696K 0.79% 24
2018
Q1
$24M Sell
713,835
-36,416
-5% -$1.25M 0.81% 24
2017
Q4
$25.8M Sell
750,251
-34,601
-4% -$1.18M 0.9% 24
2017
Q3
$26.6M Buy
784,852
+16,749
+2% +$538K 0.97% 21
2017
Q2
$24.5M Buy
768,103
+10,864
+1% +$343K 0.95% 21
2017
Q1
$24.6M Sell
757,239
-8,543
-1% -$269K 0.99% 20
2016
Q4
$23.6M Buy
765,782
+1,773
+0.2% +$54.1K 1% 17
2016
Q3
$24.5M Sell
764,009
-1,881
-0.2% -$62.9K 1.07% 17
2016
Q2
$25.6M Sell
765,890
-11,118
-1% -$355K 1.13% 14
2016
Q1
$21.8M Buy
777,008
+21,209
+3% +$606K 0.97% 19
2015
Q4
$23.1M Sell
755,799
-22,198
-3% -$698K 1.05% 16
2015
Q3
$23.2M Sell
777,997
-41,306
-5% -$1.32M 1.13% 15
2015
Q2
$26.1M Buy
819,303
+43,096
+6% +$1.4M 1.16% 14
2015
Q1
$25.6M Buy
776,207
+15,828
+2% +$503K 1.17% 13
2014
Q4
$22.5M Sell
760,379
-38,299
-5% -$1.1M 1.07% 13
2014
Q3
$22.4M Buy
798,678
+15,318
+2% +$430K 1.09% 14
2014
Q2
$22.1M Buy
783,360
+5,107
+0.7% +$146K 1.09% 14
2014
Q1
$23.7M Buy
778,253
+2,267
+0.3% +$67.6K 1.21% 13
2013
Q4
$22.6M Sell
775,986
-9,620
-1% -$280K 1.16% 15
2013
Q3
$21.4M Buy
785,606
+11,722
+2% +$319K 1.16% 14
2013
Q2
$20.6M Buy
+773,884
New +$21.4M 1.15% 15

Other funds holding PFE

Whittier Trust's PFE Position: Q2 2026 in Review

Whittier Trust reduced its Pfizer (PFE) stake by 22% in Q2 2026, selling an estimated $691K and leaving 93,334 shares worth $2.21M. The position accounts for 0.02% of the portfolio, ranked #287.

Whittier Trust first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $29.7M in Q4 2021. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Whittier Trust held 93,334 shares of Pfizer worth $2.21M as of Q2 2026.
  • Whittier Trust sold 26,423 Pfizer shares in Q2 2026, an estimated $691K.
  • Pfizer made up 0.02% of Whittier Trust's portfolio in Q2 2026, its #287 holding.
  • Whittier Trust first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
  • Whittier Trust's Pfizer position peaked at $29.7M in Q4 2021.
  • 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Whittier Trust's 13F filing for Q2 2026, filed 28 Jul 2026.